Peptide therapy, decoded.

200+ clinical monographs, interactive dosing calculators, and community reviews — all PubMed-referenced and free to access.

200+ Monographs·14 Clinical Tools·37 Languages·PubMed-Referenced·No Pharmacy Affiliations

Latest Research & Education

Article

Peptide Angio-3 Attenuates Pulmonary Fibrosis Via Modulation of Coagulation Factor Xa-PAR-1 Signaling Axis

Angio-3, a 10-residue peptide derived from human plasminogen kringle 3, demonstrated significant antifibrotic activity in pulmonary fibrosis models by functioning as a PAR-1 antagonist that disrupts the coagulation factor Xa-PAR-1 signaling axis. The peptide inhibited fibroblast invasion and migration with a favorable safety profile—no adverse effects at 0.5 mg/kg/day and only mild hepatomegaly at supratherapeutic doses.

Peptide Publicus Editorial··1 min read
Evidence-based
Guides

肽安全吗:临床研究证据全面解析

肽安全吗?本文基于临床研究证据,系统梳理肽类药物的安全性数据,涵盖NMPA批准的肽类药物不良反应率、国内外临床试验结果及中国研究者的最新发现,帮助您科学评估肽的安全性。

Peptide Publicus Editorial··1 min read
Evidence-based
Review

Antimicrobial Peptides Show Promise as Cancer Therapeutics: A 2026 Systematic Review

A new review in Frontiers in Medicine evaluates antimicrobial peptides (AMPs) as anticancer agents, finding selective cytotoxicity against tumor cells via membrane disruption and apoptosis induction, though clinical evidence remains limited to early-phase trials.

Peptide Publicus Editorial··2 min read
Evidence-based
Article

Pemvidutide Achieves MASH Resolution in Phase 2b IMPACT Trial

The Lancet published Phase 2b results for pemvidutide, a dual GLP-1/glucagon agonist, showing significant MASH resolution without worsening fibrosis at 24 weeks. FDA granted Breakthrough Therapy designation in January 2026.

Peptide Publicus Editorial··2 min read
Evidence-based
Article

Retatrutide Achieves 28.7% Weight Loss in TRIUMPH-4 Phase 3 Trial

Eli Lilly's triple GIP/GLP-1/glucagon agonist retatrutide achieved an average 28.7% body weight reduction at 68 weeks in the pivotal TRIUMPH-4 trial — the largest weight loss ever reported for any anti-obesity medication in Phase 3.

Peptide Publicus Editorial··2 min read
Evidence-based
Informational

什么是肽?肽在体内如何发挥作用:完全指南

肽是由2-50个氨基酸通过肽键连接而成的短链分子,在人体中充当信号传递者、激素和神经递质。本文从分子结构、合成机制、生理功能到中国NMPA监管框架,全面解析肽的科学原理与应用前景,帮助您建立对肽类物质的系统认知。

Peptide Publicus Editorial··2 min read
Evidence-based

Real Experiences from Real UsersNEW

BPC-157
Worth it

Game-changer for my knee recovery

After 6 weeks of subcutaneous injections, the chronic tendon pain I'd had for 2 years was down to almost nothing. Combined with PT, the results were remarkable.

Verified user · 8 weeks

Semaglutide
Worth it

Steady weight loss, minimal sides

Lost 14 lbs over 3 months on the titration schedule. Nausea was real the first 2 weeks but manageable. Worth it for the appetite control alone.

Verified user · 12 weeks

CJC-1295 + Ipamorelin
Worth it

Best GH stack I've tried

Noticeably better sleep by week 2, improved recovery from training by week 4. Skin quality improved. No water retention like with GHRP-6.

Verified user · 16 weeks

200+

Monographs

14

Interactive Tools

37

Languages

100%

Independent

掌握最新动态

临床更新、行业新闻、新研究摘要和工具发布通知。

我们尊重你的隐私。可随时取消订阅。